Compare 2 diseases with and without genetic evidence (e.g. COPD and pulmonary fibrosis) - which successful targets are prioritized by single-cell evidence?
Why is there no genetic evidence for some of these diseases? Is it lack of GWAS studies or no significant hits?
Are targets with sc evidence associated with GWAS variants for lung function?